Moreover, various biomarkers were selected to assist in tumour diagnosis, such as CD34, vascular endothelial growth factor, β-catenin, B cell leukaemia/lymphoma 2 (Bcl-2), epidermal growth factor receptor (EGFR), and p53 [7–9]. This evidence concerns the gene BCL2 and neoplasm.